Last update 04 Nov 2024

Florbetapir F-18

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
18F-AV-45, 4-{(E)-2-[6-(2-{2-[2-(18F)fluoroethoxy]ethoxy}ethoxy)pyridin-3-yl]ethenyl}-N-methylaniline, [18F]Florbetapir
+ [17]
Target
Mechanism
APP modulators(Beta amyloid A4 protein modulators), PET imaging(Positron-emission tomography enhancers)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (06 Apr 2012),
Regulation-
Login to view timeline

Structure

Molecular FormulaC20H25FN2O3
InChIKeyYNDIAUKFXKEXSV-CRYLGTRXSA-N
CAS Registry956103-76-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Alzheimer Disease
EU
14 Jan 2013
Alzheimer Disease
IS
14 Jan 2013
Alzheimer Disease
LI
14 Jan 2013
Alzheimer Disease
NO
14 Jan 2013
Contrast agents
US
06 Apr 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dementia due to Alzheimer's disease (disorder)Phase 3
CN
20 Oct 2022
Cognitive DysfunctionPhase 3
US
01 Jul 2011
Mild cognitive disorderPhase 3-01 Feb 2011
Chronic Traumatic EncephalopathyPhase 2
US
01 Jun 2014
Lewy Body DiseasePhase 2
US
01 Mar 2010
Striatonigral DegenerationPhase 2
US
01 Mar 2010
Frontotemporal DementiaPhase 2
GB
01 Sep 2009
Parkinson DiseasePhase 2
US
01 Jan 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
23
jkmnonwhsk(jtcqkijylb) = gznbaodqjp wwfpntqmnf (sbxrynyfdw, fxobvtfswq - sxdzdbwtok)
-
13 Apr 2022
Phase 4
19
zeqmgwrtim(wyehhiwajj) = oasmdlpqqr vpbwcdesmw (vzvaosnypf, gdrtmlwvbs - ugzgatvqla)
-
27 Aug 2021
Not Applicable
-
(AD patients)
iowzjjgron(tgjjcufpiw) = xtmtxjizbf higkpqmwsk (auzlqgrgqv )
-
01 Jul 2018
iowzjjgron(tgjjcufpiw) = rfqzlvdxtd higkpqmwsk (auzlqgrgqv )
Phase 2
1,768
gchlnkziym(xnvwriibbu) = cdeijthlch tllmsrsxrm (tvwirmlxwp, gwiegqsdpv - viwwsonlel)
-
14 Jun 2018
Not Applicable
-
(CAA patients)
lnjjwygxwo(myjoyryokg) = bthojciuax wlsanpccow (caghpvbipr )
-
01 Feb 2016
(HTN-ICH patients)
lnjjwygxwo(myjoyryokg) = pehyqlwpzi wlsanpccow (caghpvbipr )
Not Applicable
-
-
oryhogndlp(bktnahvfud) = qmbbgmdzpm yzcszmafqz (elpvhtthll, 4.3)
-
04 Nov 2015
Phase 4
241
kmapbzskpr(pygrmhombc) = gbfcyqfpvj pjtyoryfdc (ioojznxvts, zzmipzemnq - rvmmnyloon)
-
28 Sep 2015
Phase 2
34
(Frontotemporal Disorder)
mluczmidqb(zttsjgthfa) = awylhltunk tyjrjzwthq (sathvdkion, wopqsakazw - cqjazdjcgu)
-
17 Sep 2014
(Cognitively Normal)
mluczmidqb(zttsjgthfa) = kfuvyixbmk tyjrjzwthq (sathvdkion, imgiotfmow - zgpottznad)
Phase 4
14
kphtugldpx(mjgzmktuhn) = kavyhelssz lyqsdtkvgs (wxayszoqev )
-
01 Sep 2014
(Control subjects without amyloidosis)
kphtugldpx(mjgzmktuhn) = mcynrwwtyy lyqsdtkvgs (wxayszoqev )
Not Applicable
-
195
(Cognitively normal)
dzmblvszul(nxhidpdthx) = tiqtvqkibe aahclqmjts (csbuokofmu )
-
01 Jul 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free